Humanistic burden of living with anaplastic lymphoma kinase-positive non-small-cell lung cancer: findings from the ALKConnect patient insight network and research platform.

Lung Cancer Manag · 2020 · PMC7724653 · PMID 33318754

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

ALKConnect demonstrated that disease progression, HRQoL, fatigue/sleep/drowsiness, ALK TKI+ treatment and employment may be significant factors for improving the quality of care of patients with ALK+ NSCLC.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.